Profile
Michael J.
Berendt is currently the Executive Chairman at Anchor Therapeutics, Inc. He previously served as the President & Chief Executive Officer at Aegera Therapeutics, Inc. and as the Group Director-Drug Discovery at Pfizer Inc. He has also served as an Independent Director at Waters Corp.
and as a Director at Onyx Pharmaceuticals, Inc. and Myriad Genetics, Inc. Additionally, he was the Managing Director at AEA Investors LP and RCT BioVentures.
He served as the Director, Chief Executive & Scientific Officer at Telesta Therapeutics, Inc. and as a Director at Northstar Neuroscience, Inc., Catalyst Bioscience, Inc., Trillium Therapeutics, Inc., Alethia Biotherapeutics, Inc., Research Corporation Technologies, Inc., Neomed Institute, and ProMetic Plasma Resources, Inc. He holds a doctorate degree from Drexel University, a graduate degree from Miami University, and an undergraduate degree from Ohio Dominican University.
Michael Berendt active positions
| Companies | Position | Start |
|---|---|---|
Anchor Therapeutics, Inc.
Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Chairman | - |
Former positions of Michael Berendt
| Companies | Position | End |
|---|---|---|
| WATERS CORPORATION | Director/Board Member | 04/10/2021 |
| TELESTA THERAPEUTICS INC | Chief Executive Officer | 31/10/2016 |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Director/Board Member | 05/06/2014 |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Chief Executive Officer | 30/06/2011 |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 30/11/2005 |
Training of Michael Berendt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Waters Corp.
Waters Corp. Medical SpecialtiesHealth Technology Designs, manufactures, sells and services analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
AEA Investors LP
AEA Investors LP Investment ManagersFinance AEA Investors invests in middle-market companies located across the globe primarily in North America and Europe with an enterprise value of USD 400 million - 2.5 billion and an EBITDA of USD 5 - 200 million. The firm focuses on companies operating in the fields of industrial & industrial services, tech-enabled business services and tech-enabled healthcare services. It participates in buyout, growth, and debt transactions with an investment size of USD 50 – 250 million. The firm makes co-investments and acquires majority and minority interest. | Finance |
Telesta Therapeutics, Inc.
Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets | Health Technology |
Northstar Neuroscience, Inc.
Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Health Technology |
Catalyst Bioscience, Inc. /Old/
Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Health Technology |
Anchor Therapeutics, Inc.
Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Finance |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ohio Dominican University
Ohio Dominican University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
Research Corporation Technologies, Inc.
Research Corporation Technologies, Inc. Financial ConglomeratesFinance Provides investment related services | Finance |
Neomed Institute
Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies | Health Technology |
ProMetic Plasma Resources, Inc.
ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Operates plasma donation centers | Health Services |
- Stock Market
- Insiders
- Michael Berendt
















